JP2016501066A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501066A5
JP2016501066A5 JP2015542401A JP2015542401A JP2016501066A5 JP 2016501066 A5 JP2016501066 A5 JP 2016501066A5 JP 2015542401 A JP2015542401 A JP 2015542401A JP 2015542401 A JP2015542401 A JP 2015542401A JP 2016501066 A5 JP2016501066 A5 JP 2016501066A5
Authority
JP
Japan
Prior art keywords
solution
composition
blood vessel
subject
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015542401A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/060145 external-priority patent/WO2014076660A1/en
Publication of JP2016501066A publication Critical patent/JP2016501066A/ja
Publication of JP2016501066A5 publication Critical patent/JP2016501066A5/ja
Pending legal-status Critical Current

Links

JP2015542401A 2012-11-14 2013-11-14 血管塞栓システム Pending JP2016501066A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261726250P 2012-11-14 2012-11-14
US61/726,250 2012-11-14
PCT/IB2013/060145 WO2014076660A1 (en) 2012-11-14 2013-11-14 Vascular embolic system

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2018032093A Division JP2018086425A (ja) 2012-11-14 2018-02-26 血管塞栓システム
JP2019091205A Division JP2019122875A (ja) 2012-11-14 2019-05-14 血管塞栓システム

Publications (2)

Publication Number Publication Date
JP2016501066A JP2016501066A (ja) 2016-01-18
JP2016501066A5 true JP2016501066A5 (https=) 2019-02-14

Family

ID=49725176

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015542401A Pending JP2016501066A (ja) 2012-11-14 2013-11-14 血管塞栓システム
JP2018032093A Pending JP2018086425A (ja) 2012-11-14 2018-02-26 血管塞栓システム
JP2019091205A Pending JP2019122875A (ja) 2012-11-14 2019-05-14 血管塞栓システム
JP2021114234A Withdrawn JP2021164739A (ja) 2012-11-14 2021-07-09 血管塞栓システム
JP2023103314A Pending JP2023115128A (ja) 2012-11-14 2023-06-23 血管塞栓システム
JP2024231414A Pending JP2025031996A (ja) 2012-11-14 2024-12-26 血管塞栓システム

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2018032093A Pending JP2018086425A (ja) 2012-11-14 2018-02-26 血管塞栓システム
JP2019091205A Pending JP2019122875A (ja) 2012-11-14 2019-05-14 血管塞栓システム
JP2021114234A Withdrawn JP2021164739A (ja) 2012-11-14 2021-07-09 血管塞栓システム
JP2023103314A Pending JP2023115128A (ja) 2012-11-14 2023-06-23 血管塞栓システム
JP2024231414A Pending JP2025031996A (ja) 2012-11-14 2024-12-26 血管塞栓システム

Country Status (5)

Country Link
US (3) US20160287744A1 (https=)
EP (1) EP2919826B1 (https=)
JP (6) JP2016501066A (https=)
HK (1) HK1215200A1 (https=)
WO (1) WO2014076660A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
RU2016139369A (ru) 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
BR112016019510A2 (pt) 2014-03-10 2017-10-24 3 D Matrix Ltd esterilização e filtração de composições de peptídeos
ES2843324T3 (es) * 2014-11-18 2021-07-16 Maximum Fidelity Surgical Simulations Llc Reconstitución de la circulación post mortem
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
BR112018068941A2 (pt) * 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
MX2018011201A (es) * 2016-03-18 2018-11-22 3 D Matrix Ltd Oclusion de fuga de liquido cefalorraquideo.
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
WO2019094959A1 (en) 2017-11-13 2019-05-16 Fernandez Joss Reconstitution of post mortem circulation, specialized methods and procedures
US11716989B2 (en) 2019-04-16 2023-08-08 Maximum Fidelity Surgical Simulations, LLC Cadaver preservation systems and methods
US11915610B2 (en) 2019-05-15 2024-02-27 Maximum Fidelity Surgical Simulations, LLC Cadaverous heart model
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10127754A (ja) * 1996-11-06 1998-05-19 Koken Co Ltd コラーゲンからなる塞栓材
JP5255274B2 (ja) * 2004-07-06 2013-08-07 スリーディー マトリックス， インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
EP1799232B1 (en) * 2004-10-12 2015-10-07 FMC Biopolymer AS Self-gelling alginate systems and uses thereof
US9987221B2 (en) * 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
JP2012100680A (ja) * 2009-03-04 2012-05-31 Terumo Corp 血管内用処置材
WO2011014722A2 (en) * 2009-07-30 2011-02-03 Cook Incorporated Erodible embolization material
US20110117195A1 (en) * 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
CN103442742B (zh) * 2011-03-30 2016-08-10 东丽株式会社 生物降解性粒子、血管栓塞材料及生物降解性粒子的制造方法
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system

Similar Documents

Publication Publication Date Title
JP2016501066A5 (https=)
Yang et al. mTOR-mediated immunometabolic reprogramming nanomodulators enable sensitive switching of energy deprivation-induced microglial polarization for Alzheimer’s disease management
Lam et al. Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveries
Deng et al. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib
ES2658953T3 (es) Combinaciones y usos de los mismos
CN110022867A (zh) 高迁移率族蛋白box i突变体
Chugh et al. Cerebral vasospasm and delayed cerebral ischemia: Review of literature and the management approach
JP2014513722A5 (https=)
JP2016513523A5 (https=)
ES2657901T3 (es) Utilidad ampliada de las micropartículas derivadas de glóbulos rojos (RMP) para el tratamiento de la hemorragia
CN104906049B (zh) 一种海藻酸钠微球血管栓塞剂及其制备方法
CN105520934B (zh) 含笑内酯二甲基胺的应用
CN115337281B (zh) 一种靶向的工程化载药杂化细胞膜囊泡的制备方法及其应用
Soliman et al. Miktoarm star micelles containing curcumin reduce cell viability of sensitized glioblastoma
Zhao et al. Combined treatment of sodium ferulate, n‐butylidenephthalide, and ADSC s rehabilitates neurovascular unit in rats after photothrombotic stroke
US10220019B2 (en) Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide
Zhang et al. Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation
JP2016502527A5 (https=)
Li et al. Challenges of mesenchymal stem cells in the clinical treatment of COVID-19
US20200199681A1 (en) Mda-7 cancer therapies and methods of detecting biomolecules
CN110279673B (zh) AuNP@PP/poly(I:C)及其制备方法与其在制备治疗胶质瘤药物中的应用
AU2020208472B2 (en) Fibroblasts and microvesicles thereof for reduction of toxicity associated with cancer immunotherapy
CN107921075A (zh) 用于治疗肿瘤的细小病毒制剂
CN120617283A (zh) 基于dna损伤激活nkt细胞的抗白血病药物组合物及其应用
He et al. Anatomical and clinical study of lingual arterial chemoembolization for tongue carcinoma